Pomegranate peel extract supplementation led to significant improvements in liver enzymes (ALT, AST), triglycerides, HDL-C, and hs-CRP in NAFLD patients.
No significant change was observed in LDL-C, total cholesterol, other liver function markers, or liver steatosis grade.
The findings support the antioxidant and anti-inflammatory potential of pomegranate peel as an adjunct in NAFLD management.
Larger and longer-term studies are needed to confirm efficacy and safety.
